Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             20 results found
no title author magazine year volume issue page(s) type
1 Anti-HER2 therapy for metastatic breast cancer in low- and middle-income countries: bridging the gap between clinical trials and real life Soares, Leonardo Ribeiro

181 3 p. 693-694
article
2 A prospective cohort study to analyze the interaction of tumor-to-breast volume in breast conservation therapy versus mastectomy with reconstruction Dolen, Utku

181 3 p. 611-621
article
3 Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography Heydon-White, Asha

181 3 p. 635-644
article
4 Breast sensibility in bilateral autologous breast reconstruction with unilateral sensory nerve coaptation Bijkerk, Ennie

181 3 p. 599-610
article
5 Chemotherapy use near the end-of-life in patients with metastatic breast cancer Edman Kessler, Luisa

181 3 p. 645-651
article
6 Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy O’Toole, Sharon A.

181 3 p. 571-580
article
7 Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015 O’Donnell, Peter H.

181 3 p. 623-633
article
8 Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts Jia, Mengmeng

181 3 p. 589-597
article
9 Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review Niño de Guzmán, Ena

181 3 p. 499-518
article
10 HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas Shen, Tiansheng

181 3 p. 519-527
article
11 Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment? Altundag, Kadri

181 3 p. 691
article
12 Medical costs associated with metastatic breast cancer in younger, midlife, and older women Trogdon, Justin G.

181 3 p. 653-665
article
13 MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients Hunt, Brian G.

181 3 p. 529-540
article
14 Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer Aljohani, Abrar I.

181 3 p. 541-551
article
15 PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies Stovgaard, E. S.

181 3 p. 553-560
article
16 Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors Wang, Chun

181 3 p. 679-689
article
17 Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium Dietz, Jill R.

181 3 p. 487-497
article
18 The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers Obdeijn, Inge-Marie

181 3 p. 581-588
article
19 Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study Gómez-Acebo, Inés

181 3 p. 667-678
article
20 Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study Wang, Ruo-Xi

181 3 p. 561-570
article
                             20 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands